Skip to main content

Advertisement

Log in

Success rate in micropulse diode laser treatment with regard to lens status, refractive errors, and glaucoma subtypes

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) considering different characteristics: glaucoma subtypes and lens status.

Methods

A retrospective case-series study was designed to evaluate intraocular pressure (IOP), and the number of IOP-lowering medications, used by glaucoma patients treated with MP-TSCPC between 2016 and 2019. Cases had a follow-up period of 12 months. Achieving an IOP reduction higher than 20%, or the decrease of at least one IOP-lowering medication, was considered a successful outcome. The same population was analyzed by classifying them in two groups as: glaucoma subtypes and lens status. The baseline spherical equivalent (SE) was also calculated for considering association with the achieved IOP.

Results

A total of 86 eyes were included. In most cases, IOP and IOP-lowering medications were decreased with a statistically significant difference (p < 0.0001), and all of them had a successful outcome. The percentage of IOP drop oscillated between 25.9% (open-angle glaucoma sub-group) and 37.5% (pseudoexfoliative glaucoma sub-group), 12 months after surgery. The difference between the groups was not statistically significant (p 0.20 and 0.32 for glaucoma subtypes and lens status, respectively). The Pearson’s coefficient obtained was low for the SE and IOP association, at the 12 -month postoperative mark (− 0.009; p < 0.001).

Conclusions

The MP-TSCPC treatment was successful in decreasing IOP and IOP-lowering medications, in different glaucoma subtypes. Differences between groups (glaucoma subtypes, phakic and pseudophakic eyes) were not statistically significant. No association was found between the SE and the IOP achieved value after MS-TSCPC treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Code availability

XLMiner Analysis Toolpak Frontline Systems Inc. was used. It is a free software to perform statistical analysis in Google Sheets.

References

  1. Jiang Y, Ondeck (2020) A Review of new medications and future directions of medical therapies in glaucoma. Semin Ophthalmol 35:280–286

    Article  PubMed  Google Scholar 

  2. Cvenkel B, Kolko M (2020) Current medical therapy and future trends in the management of glaucoma treatment. J Ophthalmol 2020:6138132. https://doi.org/10.1155/2020/6138132

    Article  PubMed  PubMed Central  Google Scholar 

  3. Garg A, Gazzard G (2020) Treatment choices for newly diagnosed primary open angle and ocular hypertension patients. Eye (Lond) 34:60–71

    Article  PubMed  Google Scholar 

  4. Lee RMH, Bouremel Y, Eames I (2020) Translating minimally invasive glaucoma surgery devices. Clin Transl Sci 13:14–25

    Article  PubMed  Google Scholar 

  5. Do AT, Parikh H, Panarelli JF (2020) Subconjunctival microinvasive glaucoma surgeries: an update on the Xen gel stent and the PreserFlo MicroShunt. Curr Opin Ophthalmol 31:132–138

    Article  PubMed  Google Scholar 

  6. Mistlberger A, Liebmann JM, Tschiderer H, Ritch R, Ruckhofer J, Grabner G (2001) Diode laser transscleral cyclophotocoagulation for refractory glaucoma. J Glaucoma 10:288–293. https://doi.org/10.1097/00061198-200108000-00008

    Article  CAS  PubMed  Google Scholar 

  7. Ishida K (2013) Update on results and complications of cyclophotocoagulation. Curr Opin Ophthalmol 24:102–110

    Article  PubMed  Google Scholar 

  8. Tan AM, Chockalingam M, Aquino MC, Lim ZI, See JL, Chew PT (2010) Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol 38:266–272

    Article  PubMed  Google Scholar 

  9. Aquino MC, Barton K, Tan AM, Li X, Loon SC, Chew PT (2015) Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol 43:40–46

    Article  PubMed  Google Scholar 

  10. Emanuel ME, Grover DS, Fellman RL, Godfrey DG, Smith O, Butler MR et al (2017) Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma 26:726–729

    Article  PubMed  Google Scholar 

  11. Williams AL, Moster MR, Rahmatnejad K, Resende AF, Horan T, Reynolds M et al (2018) Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma 27:445–449

    Article  PubMed  Google Scholar 

  12. Sanchez FG, Lerner F, Sampaolesi J, Noecker R, Becerra N, Iribarren G et al (2018) Efficacy and safety of micropulse® transscleral cyclophotocoagulation in glaucoma. Arch Soc Esp Oftalmol 93:573–579

    Article  CAS  PubMed  Google Scholar 

  13. Zaarour K, Abdelmassih Y, Arej N, Cherfan G, Tomey KF, Khoueir Z (2019) Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients. J Glaucoma 28:270–275

    Article  PubMed  Google Scholar 

  14. Logioco C, Perrone LD, Caruso D, Albertazzi R, Valvecchia G, Zanutigh V (2020) Assessment of efficacy and safety of micropulse diode laser treatment in glaucoma: one year follow-up. Arch Soc Esp Oftalmol 95:327–333

    Article  CAS  PubMed  Google Scholar 

  15. de Crom RMPC, Slangen CGMM, Kujovic-Aleksov S, Webers CAB, Berendschot TTJM, Beckers HJM (2020) Micropulse trans-scleral cyclophotocoagulation in patients With glaucoma: 1 and 2-year treatment outcomes. J Glaucoma 29:794–798

    Article  PubMed  Google Scholar 

  16. Liu GJ, Mizukawa A, Okisaka S (1994) Mechanism of intraocular pressure decrease after contact transscleral continuous-wave Nd:YAG laser cyclophotocoagulation. Ophthalmic Res 26:65–79

    Article  CAS  PubMed  Google Scholar 

  17. Tsujisawa T, Ishikawa H, Uga S, Asakawa K, Kono Y, Mashimo K et al (2020) Morphological changes and potential mechanisms of intraocular pressure reduction after micropulse transscleral cyclophotocoagulation in rabbits. Ophthalmic Res. https://doi.org/10.1159/000510596

    Article  PubMed  Google Scholar 

  18. Sarrafpour S, Saleh D, Ayoub S, Radcliffe NM (2019) Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes. Ophthalmol Glaucoma 2:167–171

    Article  PubMed  Google Scholar 

  19. Masis Solano M, Lin SC (2018) Cataract, phacoemulsification and intraocular pressure: Is the anterior segment anatomy the missing piece of the puzzle? Prog Retin Eye Res 64:77–83. https://doi.org/10.1016/j.preteyeres.2018.01.003

    Article  PubMed  Google Scholar 

  20. Wang SY, Azad AD, Lin SC, Hernandez-Boussard T, Pershing S (2020) Intraocular pressure changes after cataract surgery in patients with and without glaucoma: an informatics-based approach. Ophthalmol Glaucoma 3(5):343–349. https://doi.org/10.1016/j.ogla.2020.06.002

    Article  PubMed  PubMed Central  Google Scholar 

  21. Grødum K, Heijl A, Bengtsson B (2001) Refractive error and glaucoma. Acta Ophthalmol Scand 79:560–566

    Article  PubMed  Google Scholar 

  22. Marcus MW, de Vries MM, Junoy Montolio FG, Jansonius NM (2001) Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. Ophthalmology 118:1989-1994.e2

    Article  Google Scholar 

  23. Qiu M, Wang SY, Singh K, Lin SC (2013) Association between myopia and glaucoma in the United States population. Invest Ophthalmol Vis Sci 54:830–835

    Article  PubMed  PubMed Central  Google Scholar 

  24. Shen L, Melles RB, Metlapally R, Barcellos L, Schaefer C, Risch N et al (2016) The association of refractive error with glaucoma in a multiethnic population. Ophthalmology 123:92–101

    Article  PubMed  Google Scholar 

  25. Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S (2017) Glaucoma. Lancet 390(10108):2183–2193. https://doi.org/10.1016/S0140-6736(17)31469-1

    Article  PubMed  Google Scholar 

  26. Wang L, Huang W, Huang S, Zhang J, Guo X, Friedman DS et al (2019) Ten-year incidence of primary angle closure in elderly Chinese: the Liwan Eye Study. Br J Ophthalmol 103:355–360

    Article  PubMed  Google Scholar 

  27. Varikuti VNV, Shah P, Rai O, Chaves AC, Miranda A, Lim BA et al (2019) Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision. J Glaucoma 28:901–905

    Article  PubMed  Google Scholar 

  28. Vig N, Ameen S, Bloom P, Crawley L, Normando E, Porteous A et al (2020) Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma. Graefes Arch Clin Exp Ophthalmol 258:1073–1079

    Article  PubMed  Google Scholar 

  29. Laruelle G, Pourjavan S, Janssens X, Marinescu-George C, Boustani G (2021) Real-life experience of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in advanced and uncontrolled cases of several glaucoma types: a multicentric retrospective study. Int Ophthalmol 41(10):3341–3348. https://doi.org/10.1007/s10792-021-01896-w

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge Rodrigo M. Torres M.D. Ph.D. for his scientific advice.

Funding

None; this research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by VZ, LDP, GGC, FP, GV, and CL. The first draft of the manuscript was written by VZ and CL, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Virginia Zanutigh.

Ethics declarations

Conflict of interests

The authors declare that they have no competing interests.

Ethical approval

The study was conducted following the Helsinki tenets in a private clinic in Buenos Aires (Centro de Ojos Quilmes), Argentina, after the Institutional Review Board approved the study protocol.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zanutigh, V., Perrone, L.D., Gómez-Caride, G. et al. Success rate in micropulse diode laser treatment with regard to lens status, refractive errors, and glaucoma subtypes. Int Ophthalmol 43, 2407–2417 (2023). https://doi.org/10.1007/s10792-023-02640-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-023-02640-2

Keywords

Navigation